North Star Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

North Star Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.8K	Hold	100	–	–	﹤0.01%	974
2025 Q4	$12.2K	Sell	100 -75	-43%	-$8.6K	﹤0.01%	924
2025 Q3	$17.5K	Hold	175	–	–	﹤0.01%	828
2025 Q2	$14.5K	Hold	175	–	–	﹤0.01%	834
2025 Q1	$14.2K	Hold	175	–	–	﹤0.01%	800
2024 Q4	$15.8K	Hold	175	–	–	﹤0.01%	795
2024 Q3	$17.3K	Hold	175	–	–	﹤0.01%	751
2024 Q2	$16.2K	Hold	175	–	–	﹤0.01%	749
2024 Q1	$16.6K	Hold	175	–	–	﹤0.01%	773
2023 Q4	$15.6K	Hold	175	–	–	﹤0.01%	759
2023 Q3	$12.8K	Hold	175	–	–	﹤0.01%	796
2023 Q2	$14.6K	Hold	175	–	–	﹤0.01%	785
2023 Q1	$13.3K	Hold	175	–	–	﹤0.01%	824
2022 Q4	$14.5K	Buy	175 +25	+17%	+$2.02K	﹤0.01%	794
2022 Q3	$12K	Hold	150	–	–	﹤0.01%	777
2022 Q2	$11K	Hold	150	–	–	﹤0.01%	817
2022 Q1	$13K	Hold	150	–	–	﹤0.01%	825
2021 Q4	$17K	Sell	150 -725	-83%	-$87.4K	﹤0.01%	800
2021 Q3	$110K	Hold	875	–	–	0.01%	460
2021 Q2	$118K	Buy	875 +725	+483%	+$95.3K	0.01%	455
2021 Q1	$20K	Hold	150	–	–	﹤0.01%	698
2020 Q4	$21K	Hold	150	–	–	﹤0.01%	671
2020 Q3	$17K	Hold	150	–	–	﹤0.01%	686
2020 Q2	$17K	Hold	150	–	–	﹤0.01%	658
2020 Q1	$12K	Hold	150	–	–	﹤0.01%	704
2019 Q4	$14K	Hold	150	–	–	﹤0.01%	772
2019 Q3	$11K	Buy	+150	New	+$12.5K	﹤0.01%	810
2019 Q2	–	Sell	-150	Closed	-$14K	–	948
2019 Q1	$14K	Hold	150	–	–	﹤0.01%	777
2018 Q4	$11K	Hold	150	–	–	﹤0.01%	795
2018 Q3	$14K	Hold	150	–	–	﹤0.01%	788
2018 Q2	$14K	Hold	150	–	–	﹤0.01%	794
2018 Q1	$13K	Hold	150	–	–	﹤0.01%	809
2017 Q4	$13K	Hold	150	–	–	﹤0.01%	795
2017 Q3	$13K	Hold	150	–	–	﹤0.01%	807
2017 Q2	$12K	Hold	150	–	–	﹤0.01%	808
2017 Q1	$10K	Hold	150	–	–	﹤0.01%	808
2016 Q4	$9K	Hold	150	–	–	﹤0.01%	766
2016 Q3	$10K	Hold	150	–	–	﹤0.01%	633
2016 Q2	$8K	Hold	150	–	–	﹤0.01%	657
2016 Q1	$8K	Hold	150	–	–	﹤0.01%	618
2015 Q4	$11K	Hold	150	–	–	﹤0.01%	577
2015 Q3	$9K	Hold	150	–	–	﹤0.01%	639
2015 Q2	$13K	Hold	150	–	–	﹤0.01%	559
2015 Q1	$11K	Hold	150	–	–	﹤0.01%	593
2014 Q4	$9K	Hold	150	–	–	﹤0.01%	624
2014 Q3	$8K	Hold	150	–	–	﹤0.01%	546
2014 Q2	$8K	Hold	150	–	–	﹤0.01%	592
2014 Q1	$7K	Buy	+150	New	+$7.68K	﹤0.01%	573

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

North Star Investment Management's XBI Position: Q1 2026 in Review

North Star Investment Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 100 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #974.

North Star Investment Management first reported a position in XBI in Q1 2014 and has held it in 48 quarters since. The position peaked at $118K in Q2 2021. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

North Star Investment Management held 100 shares of State Street SPDR S&P Biotech ETF worth $12.8K as of Q1 2026.
North Star Investment Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #974 holding.
North Star Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and has held it in 48 quarters since.
North Star Investment Management's State Street SPDR S&P Biotech ETF position peaked at $118K in Q2 2021.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.